Literature DB >> 11479299

Hormone-mediated dephosphorylation of specific histone H1 isoforms.

G C Banks1, L J Deterding, K B Tomer, T K Archer.   

Abstract

We have previously shown a connection between histone H1 phosphorylation and the transcriptional competence of the hormone inducible mouse mammary tumor virus (MMTV) promoter. Prolonged exposure of mouse cells to dexamethasone concurrently dephosphorylated histone H1 and rendered the MMTV promoter refractory to hormonal stimulation and, therefore, transcriptionally unresponsive. Using electrospray mass spectrometry, we demonstrate here that prolonged dexamethasone treatment differentially effects a subset of the six somatic H1 isoforms in mouse cells. H1 isoforms H1.0, H1.1, and H1.2 are non-responsive to hormone whereas prolonged dexamethasone treatment effectively dephosphorylated the H1.3, H1.4, and H1.5 isoforms. The protein kinase inhibitor staurosporine, shown to dephosphorylate histone H1 and down-regulate MMTV in cultured cells, appears only to completely dephosphorylate the H1.3 isoform. These results suggest that dephosphorylation of specific histone H1 isoforms may contribute to the previously observed decrease in transcriptional competence of the MMTV promoter through the modulation of chromatin structure. In a broader sense, this work advances the hypothesis that post-translational modifications of individual histone H1 isoforms directly influence the transcriptional activation/repression of specific genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479299     DOI: 10.1074/jbc.M104641200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Unphosphorylated H1 is enriched in a specific region of the promoter when CDC2 is down-regulated during starvation.

Authors:  Xiaoyuan Song; Martin A Gorovsky
Journal:  Mol Cell Biol       Date:  2006-12-28       Impact factor: 4.272

Review 2.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 3.  Chromatin remodeling during glucocorticoid receptor regulated transactivation.

Authors:  Heather A King; Kevin W Trotter; Trevor K Archer
Journal:  Biochim Biophys Acta       Date:  2012-03-06

4.  Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.

Authors:  H Karimi Kinyamu; Jennifer B Collins; Sherry F Grissom; Pratibha B Hebbar; Trevor K Archer
Journal:  Mol Carcinog       Date:  2008-11       Impact factor: 4.784

5.  Site-specifically phosphorylated forms of H1.5 and H1.2 localized at distinct regions of the nucleus are related to different processes during the cell cycle.

Authors:  Heribert Talasz; Bettina Sarg; Herbert H Lindner
Journal:  Chromosoma       Date:  2009-07-16       Impact factor: 4.316

6.  Tissue-specific expression and post-translational modification of histone H3 variants.

Authors:  Benjamin A Garcia; C Eric Thomas; Neil L Kelleher; Craig A Mizzen
Journal:  J Proteome Res       Date:  2008-08-14       Impact factor: 4.466

7.  Histone H1 enhances synergistic activation of the MMTV promoter in chromatin.

Authors:  Ronald Koop; Luciano Di Croce; Miguel Beato
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 8.  Chromatin remodeling by nuclear receptors.

Authors:  Pratibha B Hebbar; Trevor K Archer
Journal:  Chromosoma       Date:  2003-02-26       Impact factor: 4.316

9.  The direct interaction between ASH2, a Drosophila trithorax group protein, and SKTL, a nuclear phosphatidylinositol 4-phosphate 5-kinase, implies a role for phosphatidylinositol 4,5-bisphosphate in maintaining transcriptionally active chromatin.

Authors:  Mimi K Cheng; Allen Shearn
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

Review 10.  Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations.

Authors:  Özlem Önder; Simone Sidoli; Martin Carroll; Benjamin A Garcia
Journal:  Expert Rev Proteomics       Date:  2015       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.